CEPI Awards Contract Worth Up To $19 million to Oxford University and Janssen Vaccines to Develop MERS, Lassa, and Nipah Vaccines

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a collaboration to advance the development and manufacture of a vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) along with preclinical development of novel vaccines against Lassa and Nipah viruses.

Evaluation of a Visual Triage for the Screening of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Patients

In 2017, the Saudi Ministry of Health released a visual triage system with scoring to alert healthcare workers in emergency departments and hemodialysis units for the possibility of occurrence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in their patients.